Our results suggest that IL-6, which is the key cytokine located upstream of the inflammatory cytokine cascade, increases prior to ARDS in critical COVID-19 patients, followed by an increase in acute-phase protein levels, such as CRP [9,10]. This evidence concerns the gene IL6 and acute respiratory distress syndrome.